Pyridoxal-5′-phosphate monohydrate (CAS 41468-25-1)

Pyridoxal-5′-phosphate monohydrate, also known as Pyridoxal phosphate hydrate (PPLH), a vitamin B6 metabolite, exhibits the ability to modify lysyl and valyl residues within proteins. Notably, it possesses inhibitory properties towards purinergic receptors and intracellular calcium influx. Furthermore, this compound can modify peptides and impede their precursor ionization efficiency. Research indicates that cycloserine can inhibit pyridoxal-5′-phosphate-dependent enzymes. Pyridoxal-5′-phosphate monohydrate belongs to the water-soluble derivatives of the vitamin B6 family. As a vital coenzyme, it participates in numerous biochemical reactions involving carbohydrate, protein, and fatty acid metabolism. Additionally, Pyridoxal-5′-phosphate monohydrate plays a role in neurotransmitter synthesis, contributing to normal nerve function. Moreover, it influences gene expression and facilitates DNA repair processes. Pyridoxal-5′-phosphate monohydrate finds extensive use in scientific research, particularly in the fields of biochemistry, molecular biology, and pharmacology. It serves as useful for investigating enzyme mechanisms, assessing enzyme activity, and exploring gene expression regulation. Moreover, Pyridoxal-5′-phosphate monohydrate is involved in neurotransmitter synthesis, playing a critical role in maintaining the proper functioning of the nervous system. Acting as a coenzyme, it binds to enzymes and aids in their activation, facilitating catalytic reactions through electron transfer.